Perspectives on recent reviews of aspartame cancer epidemiology
Aspartame is a dipeptide non-sugar sweetener that was first marketed in the US in carbonated beverages in 1983, before gaining prominence globally. The Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives (JECFA) and t...
Main Authors: | Julie E. Goodman, Denali N. Boon, Maia M. Jack |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Global Epidemiology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590113323000202 |
Similar Items
-
The role of study quality in aspartame and cancer epidemiology study reviews
by: Julie E. Goodman, et al.
Published: (2023-12-01) -
Aspartame and cancer – new evidence for causation
by: Philip J. Landrigan, et al.
Published: (2021-04-01) -
Quantitative recall bias analysis of the talc and ovarian cancer association
by: Julie E. Goodman, et al.
Published: (2024-06-01) -
Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France
by: Victor Maler, et al.
Published: (2023-06-01) -
Development of an HPLC Method with an ODS Column to Determine Low Levels of Aspartame Diastereomers in Aspartame.
by: Takashi Ohtsuki, et al.
Published: (2016-01-01)